View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

DKSH Holding AG: 2 directors

Two Directors at DKSH Holding AG bought 2,020 shares at between 59.500CHF and 59.858CHF. The significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...

Christian Arnold ... (+2)
  • Christian Arnold
  • Tobias Fahrenholz

ODDO : Swiss Equities Conference Feedback – Difficult Q2 but some H2 2...

ODDO BHF and Commerzbank jointly hosted the Swiss Equities Conference in Interlaken, Switzerland, from 10 to 12 June 2025. The event was attended by 64 companies (out of which 59 are listed, and with BASF one non-Swiss company). Some 125 investors met mostly (85%) C-level management in 440 meetings (one-on-one, one-to-few) and plenary sessions, resulting in some 1,100 interactions. Based on our positive assessments for Q2 & H2 2025 as well as beyond, we would like to highlight Accelleron (poten...

 PRESS RELEASE

DKSH’s 92nd Annual General Meeting 2025

DKSH Management Ltd. / Key word(s): AGMEGM/Dividend DKSH’s 92nd Annual General Meeting 2025 27.03.2025 / 17:45 CET/CEST Media releaseShareholders approved all motions with a clear majority Reelection of the current Board members seeking another term as well as the Chairman of the Board of Directors, and appointment of a new Board member Proposal of dividend increase of 4.4% to CHF 2.35 per share accepted Zurich, Switzerland, March 27, 2025 – DKSH has held its 92nd Annual General Meeting where shareholders have voted in favor of all motions by a clear majority. In total, 166 share...

 PRESS RELEASE

DKSH Technology Strengthens its Korean Business with the Acquisition o...

DKSH Management Ltd. / Key word(s): Takeover DKSH Technology Strengthens its Korean Business with the Acquisition of MDxK 26.03.2025 / 07:00 CET/CEST Media releaseDKSH has signed an agreement to acquire Molecular Diagnostics Korea Inc. (“MDxK”), a well- established player in the South-Korean life-science space. With this transaction, DKSH Technology further extends its scientific solutions business in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond. Zurich, Switzerland, March 26, 2025 – DKSH has announced...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch